Literature DB >> 7521690

The active monomeric form of macrophage inflammatory protein-1 alpha interacts with high- and low-affinity classes of receptors on human hematopoietic cells.

B R Avalos1, K J Bartynski, P J Elder, M S Kotur, W G Burton, N M Wilkie.   

Abstract

Macrophage inflammatory protein-1 alpha (MIP-1 alpha) and its human homologue GOS19.1/LD78 are members of the C-C chemokine/intercrine family of secreted proteins. They have proinflammatory properties and also inhibit cell cycle progression of hematopoietic stem cells. Characterization of MIP-1 alpha receptor(s) has been confused because of its reported aggregation to inactive forms. Using a defined monomeric form of MIP-1 alpha that is biologically active for stem cell inhibition and induction of oxidative metabolism in polymorphonuclear cells, we report the detection of high- and low-affinity receptor classes on human leukemic CD34+ blast cells, promyelocytic cells, monocytes, peripheral blood neutrophils, and T cells. Both high- and low-affinity classes are expressed simultaneously in promyelocytes and neutrophils. The calculated kd for high-affinity receptors correlates with the concentrations of MIP-1 alpha required to induce a biologic effect on stem cells and neutrophils. Cross-linking studies show that MIP-1 alpha associates with two cell surface proteins with apparent molecular masses of 92 kD and 52 kD. Direct competition binding studies combined with studies on the inhibition of stem cells show that human and murine MIP-1 alpha have different receptor-binding and biologic properties.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7521690

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  5 in total

1.  Identification of amino acids involved in the binding of hMIP-1 alpha to CC-CKR1, a MIP-1 alpha receptor found on neutrophils.

Authors:  J M Crisman; P J Elder; N M Wilkie; P E Kolattukudy
Journal:  Mol Cell Biochem       Date:  1999-05       Impact factor: 3.396

2.  Human natural killer cells produce abundant macrophage inflammatory protein-1 alpha in response to monocyte-derived cytokines.

Authors:  E M Bluman; K J Bartynski; B R Avalos; M A Caligiuri
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

3.  Human chemokines: enhancement of specific activity and effects in vitro on normal and leukemic progenitors and a factor-dependent cell line and in vivo in mice.

Authors:  H E Broxmeyer; S Cooper; N Hague; L Benninger; A Sarris; K Cornetta; S Vadhan-Raj; P Hendrie; C Mantel
Journal:  Ann Hematol       Date:  1995-11       Impact factor: 3.673

4.  Identification of novel regulators in T-cell differentiation of aplastic anemia patients.

Authors:  Anke Franzke; Robert Geffers; J Katrin Hunger; Susanne Pförtner; Wenji Piao; Philipp Ivanyi; Jens Grosse; Michael Probst-Kepper; Arnold Ganser; Jan Buer
Journal:  BMC Genomics       Date:  2006-10-19       Impact factor: 3.969

5.  The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood.

Authors:  A Aiuti; I J Webb; C Bleul; T Springer; J C Gutierrez-Ramos
Journal:  J Exp Med       Date:  1997-01-06       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.